Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 26Gynecologic 10Dermatologic 9Breast 9Genitourinary 8Thoracic 7Sarcoma 5Lymphoid 4Head & Neck 4CNS 3Plasma cell 2Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Leukemia 346Leukemia, Myeloid, Acute 289Leukemia, Lymphocytic, Chronic, B-Cell 286Lymphoma 217Myelodysplastic Syndromes 207Lymphoma, Non-Hodgkin 196Burkitt Lymphoma 160Lymphoma, Follicular 149Lymphoma, Mantle-Cell 136Lymphoma, Large B-Cell, Diffuse 135Hodgkin Disease 131Multiple Myeloma 120Lymphoma, B-Cell, Marginal Zone 118Lymphoma, Large-Cell, Immunoblastic 95Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Hematologic Neoplasms 87Myeloproliferative Disorders 85Leukemia, Myeloid, Chronic-Phase 83Leukemia, Myeloid, Accelerated Phase 80Leukemia, Myelomonocytic, Chronic 78Recurrence 72Congenital Abnormalities 68Blast Crisis 64Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Graft vs Host Disease 62Neoplasms, Plasma Cell 61Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 59Dendritic Cell Sarcoma, Interdigitating 59

Interventions

fludarabine 2aflibercept 2Magnetic Resonance Spectroscopy 2Dasatinib 2Cyclophosphamide 2Counseling 2Bupropion 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1entinostat 1defactinib 1dabrafenib 1copanlisib 1capivasertib 1binimetinib 1adavosertib 1Zinc Oxide 1X-Rays 1Varenicline 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Cyclophosphamide × Other hematologic neoplasm × Clear all
NCT07410494 2026-02-18

SELECT-CAR-NK

Essen Biotech

Phase 1/2 Recruiting
85 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

First Affiliated Hospital of Wenzhou Medical University

Phase NA Unknown
18 enrolled
GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡